UPDATED Jun 28, 2024
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
688002 | CN¥27.97 | -7.2% | -37.6% | CN¥12.4b | CN¥47.28 | PE22.8x | E27.9% | 0.4% | Tech | ||
605116 | CN¥25.03 | 10.5% | -1.0% | CN¥10.2b | CN¥31.00 | PE31.2x | E24.0% | 0.9% | Pharmaceuticals & Biotech | ||
688596 | CN¥33.00 | -10.4% | -23.8% | CN¥9.3b | CN¥46.00 | PE22.5x | E29.2% | 0.9% | Semiconductors | ||
603199 | CN¥29.80 | -3.8% | -13.7% | CN¥3.3b | CN¥41.00 | PE20x | E13.0% | 2.7% | Consumer Services | ||
301015 | CN¥23.53 | -9.1% | -15.2% | CN¥12.4b | CN¥48.00 | PE18.8x | E22.6% | 3.2% | Healthcare |